DEUCRAVACITINIB

UNII:	N0A21N6RAU
Formula:	C₂₀H₂₂N₈O₃
Preferred Substance Name:	DEUCRAVACITINIB
InChIKey:	BZZKEPGENYLQSC-FIBGUPNXSA-N

1609392-27-9
3-PYRIDAZINECARBOXAMIDE, 6-((CYCLOPROPYLCARBONYL)AMINO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)-
6-((CYCLOPROPYLCARBONYL)AMINO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)-3-PYRIDAZINECARBOXAMIDE
6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE
BMS-986165
DEUCRAVACITINIB [INN]
DEUCRAVACITINIB [JAN]
DEUCRAVACITINIB [USAN]
DEUCRAVACITINIB [WHO-DD]
SOTYKTU

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

DEUCRAVACITINIB

Synonyms and Mappings

Resources